Centric Health Corp (CHH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centric Health Corp (CHH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8050
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centric Health Corp (CHC) is a healthcare and wellness service provider. The company operates through specialty pharmacy, orthotics, and surgical and medical centres. Its pharmacies provide traditional pharmacy services such as compounding and dispensing medications, and clinical and specialty services for long term care and retirement communities and addiction management. CHC through orthotics centers provides preventive services, injury management services and lifestyle maintenance services. The company’s surgical and medical centres offers diagnostic services in colonoscopy, diagnostic ultrasound, digital x-ray and gastroscopy; and surgical services in the areas of cardiology, dermatology, general surgery, orthopaedic surgery and others. It provides services to individuals, employers, and long term care homes and retirement residences. CHC is headquartered in Toronto, Ontario, Canada.

Centric Health Corp (CHH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centric Health Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centric Health Corp, Medical Devices Deals, 2012 to YTD 2018 9
Centric Health Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Centric Health Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Centric Health Acquires 75% Stake In SmartShape Weight Loss Centres For US$1.5 Million 11
Debt Offering 13
Centric Health Completes Public Offering Of Notes Due 2018 For US$197.5 Million 13
Centric Health Completes Underwriters’ Exercise Of Over-Allotment Option Of Notes Due 2017 For US$28.2 Million 15
Centric Health Completes Private Placement Of Convertible Notes Due 2016 For US$15.2 Million 17
Centric Health Corp – Key Competitors 19
Centric Health Corp – Key Employees 20
Centric Health Corp – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 14, 2018: Centric Health Reports Q2’18 Financial Results, Announces New Strategic Direction 22
May 09, 2018: Centric Health Announces Results for the First Quarter of 2018 24
Mar 20, 2018: Centric Health Reports Fourth Quarter And Full Year of 2017 Financial Results 26
Nov 15, 2017: Centric Health Announces Results for the Third Quarter of 2017 29
May 09, 2017: Centric Health Reports Continued Strong Financial Results for First Quarter of 2017 31
Mar 07, 2017: Centric Health Reports Continued Strong Financial Results for Fourth Quarter of 2016 33
Corporate Communications 35
Apr 03, 2018: Centric Health Appoints David Murphy as President and CEO 35
Dec 15, 2017: Centric Health Enters into Consulting Arrangement with CEO and Announces New COO of Specialty Pharmacy Division and National Director of Business Development 36
Dec 04, 2017: Centric Health Announces CEO Retirement 37
Mar 30, 2017: Centric Health Announces Appointment of Independent Director 38
Other Significant Developments 39
May 02, 2018: Centric Health Provides Regulatory Update 39
Apr 05, 2018: Centric Health Collaborates with Think Research to Digitize its Specialty Pharmacy Operations 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Centric Health Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centric Health Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centric Health Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Centric Health Corp, Medical Devices Deals, 2012 to YTD 2018 9
Centric Health Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Centric Health Acquires 75% Stake In SmartShape Weight Loss Centres For US$1.5 Million 11
Centric Health Completes Public Offering Of Notes Due 2018 For US$197.5 Million 13
Centric Health Completes Underwriters' Exercise Of Over-Allotment Option Of Notes Due 2017 For US$28.2 Million 15
Centric Health Completes Private Placement Of Convertible Notes Due 2016 For US$15.2 Million 17
Centric Health Corp, Key Competitors 19
Centric Health Corp, Key Employees 20
Centric Health Corp, Other Locations 21
Centric Health Corp, Subsidiaries 21

List of Figures
Centric Health Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centric Health Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centric Health Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centric Health Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Centric Health Corp (CHH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arcadia Group Limited:企業の戦略・SWOT・財務情報
    Arcadia Group Limited - Strategy, SWOT and Corporate Finance Report Summary Arcadia Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Science Group plc (SAG):企業の財務・戦略的SWOT分析
    Science Group plc (SAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Oltchim SA (OLT):企業の財務・戦略的SWOT分析
    Summary Oltchim SA (Oltchim) is a chemical company that manufactures and markets petrochemical products. The company offers inorganic, macro molecular and organic synthesis products. Its inorganic products include caustic soda, liquid chlorine, hydrochloric acid and sodium hypochlorite. Oltchim's ma …
  • Granules India Ltd (GRANULES):製薬・医療:M&Aディール及び事業提携情報
    Summary Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, …
  • Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Danone SA:戦略・SWOT・企業財務分析
    Danone SA - Strategy, SWOT and Corporate Finance Report Summary Danone SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Medshape Inc-医療機器分野:企業M&A・提携分析
    Summary Medshape Inc (MedShape), formerly MedShape Solutions Inc is a medical device company that develops and manufactures orthopedic devices for the orthopedic healthcare markets. The company’s products include dynanail ankle arthrodesis nail, eclipse soft tissue anchor, exoshape teno soft tissue …
  • Tesaro Inc (TSRO)-医療機器分野:企業M&A・提携分析
    Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company’s first commercial product is …
  • Fox Corp (FOXA):企業の財務・戦略的SWOT分析
    Fox Corp (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • EndoCeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company's pipeline product portfolio includes drugs for various indications such as endometriosis; male hypogonadism and antiandrogens, among others. …
  • EVN AG (EVN)-エネルギー分野:企業M&A・提携分析
    Summary EVN AG (EVN) is an energy and environmental services company. It provides electricity, natural gas, heat, drinking water, wastewater treatment, thermal waste utilization, and related services. The company produces power from thermal and renewable sources. EVN procures electricity, natural ga …
  • Fair Isaac Corp (FICO):企業の財務・戦略的SWOT分析
    Fair Isaac Corp (FICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Standard Bank Group Ltd (SBK):企業の財務・戦略的SWOT分析
    Standard Bank Group Ltd (SBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ak Bars Bank:企業の戦略・SWOT・財務分析
    Ak Bars Bank - Strategy, SWOT and Corporate Finance Report Summary Ak Bars Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Union Jack Oil plc (UJO):企業の財務・戦略的SWOT分析
    Summary Union Jack Oil Plc (Union Jack Oil), formerly Union Jack Oil Ltd is an onshore oil and gas company that offers exploration and development of hydrocarbon projects. The company develops its portfolio of oil and gas assets by acquiring interests in drill ready prospects. It holds license inter …
  • Melkior Resources Inc. (MKR):企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Luminex Corp (LMNX)-医療機器分野:企業M&A・提携分析
    Summary Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technol …
  • Lensar Inc:医療機器:M&Aディール及び事業提携情報
    Summary Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers vari …
  • BlackRock Inc:戦略・SWOT・企業財務分析
    BlackRock Inc - Strategy, SWOT and Corporate Finance Report Summary BlackRock Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sparton Resources Inc (SRI):企業の財務・戦略的SWOT分析
    Summary Sparton Resources Inc (Sparton Resources) is a diversified company that acquires and develops oil and gas properties in North America and China. The company’s products include vanadium, natural gas, crude oil, gold, and vanadium flow batteries, among others. Its energy projects comprise Sier …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆